Approval · Notice of Compliance 33786 · 2024
SOLNIXON: Notice of Compliance 33786
Issued August 9, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33786
- Date
- August 9, 2024
- Company
- Bimeda-MTC Animal Health Inc.Cambridge, Ontario, Canada
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative - Additional Product Name
- Canadian reference product
- BANAMINE (Intervet Canada Corp)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SOLNIXON | 02550474 | Marketed |
Medicinal ingredients
- FLUNIXIN MEGLUMINE 50 MG per ML